A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Sponsor and Collaborators
Roswell Park Cancer Institute
Novartis
Contact
AskRPCI 1-877-275-7724
AskRPCI@roswellpark.org
Principal Investigator
Roberto Pili, MD
Roswell Park Cancer Institute
Continue Reading
ClinicalTrials.gov Identifier
NCT01037257